Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nabil G Seidah. (2009) PCSK9 as a therapeutic target of dyslipidemia. Expert Opinion on Therapeutic Targets 13:1, pages 19-28.
Read now
Read now
Articles from other publishers (11)
Han Xue, Meng Zhang, Jianfang Liu, Jianjun Wang & Gang Ren. (2023) Structure-based mechanism and inhibition of cholesteryl ester transfer protein. Current Atherosclerosis Reports 25:4, pages 155-166.
Crossref
Crossref
Nathan B. Mantlo & Scott A. Frank. 2020. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3
339
372
.
Zhiwei Yang, Dongxiao Hao, Yizhuo Che, Lei Zhang & Shengli Zhang. 2018. Cholesterol - Good, Bad and the Heart. Cholesterol - Good, Bad and the Heart.
Shu-Yu Chen, Na Li, Tao-Li Jin, Lu Gou, Dong-Xiao Hao, Zhi-Qi Tian, Sheng-Li Zhang & Lei Zhang. (2018) Lipoprotein in cholesterol transport: Highlights and recent insights into its structural basis and functional mechanism. Chinese Physics B 27:2, pages 028702.
Crossref
Crossref
Qiao Zhang, Chunlin Deng, Lisong Fang, Wenwei Xu, Qun Zhao, Jiange Zhang, Yiping Wang & Xinsheng Lei. (2013) Synthesis and Evaluation of the Analogues of Penicillide against Cholesterol Ester Transfer Protein. Chinese Journal of Chemistry 31:3, pages 355-370.
Crossref
Crossref
Xiaodong Fang, Yulian Mou, Zhiyong Huang, Yong Li, Lijuan Han, Yanfeng Zhang, Yue Feng, Yuanxin Chen, Xuanting Jiang, Wei Zhao, Xiaoqing Sun, Zhiqiang Xiong, Lan Yang, Huan Liu, Dingding Fan, Likai Mao, Lijie Ren, Chuxin Liu, Juan Wang, Kui Li, Guangbiao Wang, Shulin Yang, Liangxue Lai, Guojie Zhang, Yingrui Li, Jun Wang, Lars Bolund, Huanming Yang, Jian Wang, Shutang Feng, Songgang Li & Yutao Du. (2012) The sequence and analysis of a Chinese pig genome. GigaScience 1:1.
Crossref
Crossref
Michael-Friedrich Boettcher, Roland Heinig, Carsten Schmeck, Christian Kohlsdorfer, Matthias Ludwig, Anja Schaefer, Sabine Gelfert-Peukert, Georg Wensing & Olaf Weber. (2012) Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein. British Journal of Clinical Pharmacology 73:2, pages 210-218.
Crossref
Crossref
Paul J. W. H. Kappelle, Arie van Tol, Bruce H. R. Wolffenbuttel & Robin P. F. Dullaart. (2011) Cholesteryl Ester Transfer Protein Inhibition in Cardiovascular Risk Management: Ongoing Trials will End the Confusion. Cardiovascular Therapeutics 29:6, pages e89-e99.
Crossref
Crossref
Olaf Weber, Hilmar Bischoff, Carsten Schmeck & Michael-Friedrich Böttcher. (2010) Cholesteryl ester transfer protein and its inhibition. Cellular and Molecular Life Sciences 67:18, pages 3139-3149.
Crossref
Crossref
Silvia Bijland, Sjoerd A.A van den Berg, Peter J. Voshol, Anita M. van den Hoek, Hans M.G Princen, Louis M. Havekes, Patrick C.N Rensen & Ko Willems van Dijk. (2010) CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice. Journal of Lipid Research 51:1, pages 97-102.
Crossref
Crossref
Menno Vergeer & Erik S.G. Stroes. (2009) The Pharmacology and Off-Target Effects of Some Cholesterol Ester Transfer Protein Inhibitors. The American Journal of Cardiology 104:10, pages 32E-38E.
Crossref
Crossref